Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. Bruger AM, et al. Among authors: van ginderachter ja, van der bruggen p. Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21. Cancer Immunol Immunother. 2019. PMID: 29785656 Free PMC article. Review.
A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors.
Sun Z, Lethé B, Zhang Y, Russo V, Colau D, Stroobant V, Boon T, van der Bruggen P. Sun Z, et al. Among authors: van der bruggen p. Cancer Immunol Immunother. 2006 Jun;55(6):644-52. doi: 10.1007/s00262-005-0066-x. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187088 Free PMC article.
Protocol to assess the suppression of T-cell proliferation by human MDSC.
Bruger AM, Vanhaver C, Bruderek K, Amodio G, Tavukçuoğlu E, Esendagli G, Gregori S, Brandau S, van der Bruggen P. Bruger AM, et al. Among authors: van der bruggen p. Methods Enzymol. 2020;632:155-192. doi: 10.1016/bs.mie.2019.05.046. Epub 2019 Jul 8. Methods Enzymol. 2020. PMID: 32000895
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma.
Gondois-Rey F, Paul M, Alcaraz F, Bourass S, Monnier J, Malissen N, Grob JJ, Bruger AM, Van Der Bruggen P, Gaudy-Marqueste C, Olive D. Gondois-Rey F, et al. Among authors: van der bruggen p. Cancers (Basel). 2021 Mar 17;13(6):1362. doi: 10.3390/cancers13061362. Cancers (Basel). 2021. PMID: 33802925 Free PMC article.
139 results